Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Basics of Health Coverage Enrollment: Strategies and Resources for New Program Staff
Annual orientation webinar is designed to introduce new program staff (or staff with new roles) to the ACE TA Center.Resource updated 10/05/2023
-
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Four things to know about Open Enrollment 2022
To help you stay on top of the latest updates, the ACE TA Center has compiled this list of four “things to know” about helping consumers navigate this year’s Marketplace Open Enrollment.Blog updated 11/09/2021
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Merging Prevention and Care Planning Groups
HIV planning groups are responsible for overseeing the planning and implementation of HIV prevention and care activities within communities. Historically, prevention and care programs have operated separate planning groups. RWHAP Part A and Part B recipients and CDC-funded prevention jurisdictions have conducted parallel planning activities, oftentimes with little collaboration or coordination. As a way to reduce duplicative planning activities and streamline the work of planning groups, a number of jurisdictions have integrated their HIV planning groups.
Resource updated 09/14/2023
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Marketplace Subsidies and Unemployment Compensation
New Marketplace subsidies are available for people who received unemployment compensation in 2021.Blog updated 12/15/2021
-
Online Course on Integrated Planning
-
Lights, Camera, Action: Introducing an Integrated HIV Prevention and Care Planning Online Course
Introduction to the newly developed online course, An Introduction to Integrated HIV Prevention and Care Planning.Resource updated 02/28/2022
-
An Introduction to HIV Prevention and Care Planning
This self-paced course from the Integrated HIV/AIDS Planning TA Center serves as an introduction to the fundamentals of integrated planning, and is designed for anyone who is new to integrated HIV prevention and care planning or anyone who would like a refresher on the basics.
By the end of this course, you will be able to:
Resource updated 07/28/2021
-
HIV Planning Body Assessment Guide: A Resource for Integrated HIV Planning Bodies
Guide to help integrated HIV planning bodies review and evaluate the effectiveness of their structure, policies and procedures, membership, and stakeholder and consumer engagement.Resource updated 09/14/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Fostering Equity in HIV Planning
In this webinar, panelists discussed the ways in which power imbalances can manifest in HIV planning bodies; how their planning bodies have sought to promote equity; and strategies that can be implemented to foster equity and mitigate power imbalances based on race, education, age, and socioeconomic status.
Resource updated 11/22/2021
-
Stay Undetectable Poster Series
Consumer-friendly poster series to spark consumers and providers to discuss treatment as prevention and use of their health coverage to support it.Resource updated 10/19/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Expanded Access to Subsidized Marketplace Insurance Plans
Did you know? Most people with very low incomes can now enroll in subsidized Marketplace coverage.Blog updated 04/14/2022